Daily Briefing
Monday, February 16, 2026
The Vibe
Healthcare AI is moving beyond pilot projects into real medication workflows and funding rounds, while diagnostic tools pile up FDA clearances. Wolters Kluwer's push into agentic AI for medication automation [1] and Anterior's $40M raise [2] signal that operational AI is finally getting serious money and enterprise commitment.
Research
•Machine learning identified ethnic-specific predictors of maternal postpartum depression, potentially enabling more targeted screening protocols [3]
•AI-enabled ECG detected left ventricular systolic dysfunction in patients with left bundle branch block, offering prognostic stratification capabilities [4]
•Skeletal muscle grading using intramuscular and intermuscular fat imaging predicted treatment outcomes for locally advanced rectal cancer [5]
•EEG monitoring protocols were developed as diagnostic tools for traumatic brain injury in a hyperbaric oxygen treatment trial [6]
Clinical Practice & Ops
•Wolters Kluwer Health launched agentic AI capabilities targeting medication workflow automation, with executive Christian Hartman calling it "foundational capabilities" [1]
•Anterior secured $40M in funding to scale its AI platform for payer operations [2]
•Hinge Health projected 2026 revenue will hit $732M, driven partly by AI investments, with shares jumping 13% after earnings [7]
Industry & Products
•FDA cleared Encora Therapeutics' wearable wrist device for essential tremor treatment [8]
•Labcorp launched Roche's FDA-cleared Alzheimer's blood test for primary care screening in patients 55 and older with cognitive decline symptoms [9]
•Agilent received FDA approval for a companion diagnostic alongside Keytruda's latest ovarian cancer indication [10]
One to Watch
Monitor whether Wolters Kluwer's medication workflow automation actually reduces pharmacy errors in real deployments — agentic AI promises are easy to make, harder to deliver safely.